Premium
Interleukin‐17 as an Effector Molecule of Innate and Acquired Immunity against Infections
Author(s) -
Matsuzaki Goro,
Umemura Masayuki
Publication year - 2007
Publication title -
microbiology and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 70
eISSN - 1348-0421
pISSN - 0385-5600
DOI - 10.1111/j.1348-0421.2007.tb04008.x
Subject(s) - biology , immunology , innate immune system , immune system , immunity , chemokine , interleukin 15 , interleukin 17 , proinflammatory cytokine , interleukin , cytokine , microbiology and biotechnology , inflammation
Interleukin (IL)‐17 is a proinflammatory cytokine which induces differentiation and migration of neutrophils through induction of cytokines and chemokines including granulocyte‐colony stimulating factor and CXCL8/IL‐8. IL‐17‐producing CD4 + T cells (Th17) have pivotal role in pathogenesis of autoimmune diseases. IL‐17 is also involved in protective immunity against various infections. IL‐17 has important role in induction of neutrophil‐mediated protective immune response against extracellular bacterial or fungal pathogens such as Klebsiella pneumoniae and Candida albicans . Importance of IL‐17 in protection against intracellular pathogens including Mycobacterium has also been reported. Interestingly, not only CD4 + T cells but atypical CD4 – CD8 – T cells expressing T cell receptor (TCR) γδ produce IL‐17, and IL‐17 producing cells participate in both innate and acquired immune response to infections. Furthermore, neutrophil induction may not be the only mechanism of IL‐17‐mediated protective immunity. IL‐17 seems to participate in host defense through regulation of cell‐mediated immunity or induction of antimicrobial peptides such as β‐defensins. In this review, we summarize recent progress on the role of IL‐17 in immune response against infections, and discuss possible application of IL‐17 in prevention and treatment of infectious diseases.